to be a companion along your journey.
What is Magnolia Paws for Compassion?
Magnolia Paws for Compassion is a special program, created by Eisai Inc., which seeks to increase access to animal assistance and raise awareness of the many benefits that interaction with animals can provide to those coping with illness, such as epilepsy.
In partnership with the Epilepsy Foundation and 4 Paws for Ability, we highlight the support that animal assistance can provide families affected by epilepsy or seizure disorders. Service and therapy dogs play a key role in the lives of those coping with illness. Service dogs are trained to provide assistance to someone with a disability and have special rights under the Americans with Disabilities Act (ADA). Therapy dogs provide psychological or physiological therapy, including emotional support.
Why Eisai Created Magnolia Paws for Compassion
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, helping to increase the benefits health care provides. Magnolia Paws for Compassion embodies Eisai's human health care (hhc) mission by involving our employees in fundraising to support animal assistance and encouraging them to have their own pets trained as therapy dogs. Once trained, employees and their dogs spend time with patients, helping to alleviate some of the emotional and physical stresses associated with illness. These interactions also allow our employees to gain a personal understanding of the patient’s journey, providing insights that can help inform and motivate their work.
Eisai’s Commitment to Advancing Epilepsy Care
One of Eisai’s key therapeutic areas of focus is epilepsy. We are dedicated to keeping people with epilepsy and their families at the forefront of all that we do. We are driven not only to advancing epilepsy treatment but to Advancing Epilepsy Care by offering treatments and meaningful resources to patients and their families. We strive to help them cope with the difficulties associated with such conditions as partial onset seizures, which account for 60% of all seizures, and seizures associated with Lennox-Gaustaut Syndrome (LGS), a severe form of early childhood-onset epilepsy.
As a company dedicated to advancing epilepsy care for patients and caregivers, Eisai is committed to helping provide educational and practical resources in an effort to help meet the needs of the epilepsy community.
At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina.
4 Paws for Ability is a nonprofit, 501(c)(3) organization whose mission is to place quality service dogs with children with disabilities and veterans who have lost use of limbs or hearing; help with animal rescue, and educate the public regarding use of service dogs in public places. 4 Paws for Ability relies on the generosity of individuals, as well as corporations, and accepts donations for operating expenses, training, food, toys, training supplies, medication, and our building fund.
The Epilepsy Foundation, a national non-profit with 48 affiliated organizations throughout the United States, has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is to stop seizures and sudden unexpected death in epilepsy (SUDEP), find a cure and overcome the challenges created by epilepsy through efforts including education, advocacy and research to accelerate ideas into therapies. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential. To learn more about epilepsy and seizure disorders, please visit the Epilepsy Foundation.